C. Shah

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.

D. Ettinger, R. Salgia, P. Lorigan, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antiangiogenic Drugs Synergize with a Membrane Macrophage Colony-Stimulating Factor-Based Tumor Vaccine to Therapeutically Treat Rats with an Established Malignant Intracranial Glioma1

A. Obenaus, S. Chong, E. Jeffes, 2005, The Journal of Immunology.

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer.

A. Gajra, N. Ready, M. Perry, 2007, Lung cancer.

Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro

M. Jadus, A. Brown, C. Shah, 2009, Phytotherapy research : PTR.

Amrubicin: a synthetic anthracyclin analogue in the treatment of extensive stage small cell lung cancer.

C. Shah, 2009, Recent patents on anti-cancer drug discovery.

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.

D. Ettinger, R. Salgia, P. Lorigan, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.